MD – HIP

`
INTRODUCTION

Compositions: Collagen, Calci phosphat, Natri clorid, water for injection.

Dosage Form: injectable solution .

Pakaging: Box 10 vials (single vial 2 ml – Extraction solution).

Uses:

MD – HIP is used in order to improve the movement of hip joint, help muscle stretching of the lumbosacral area and soothe the local pain

MD-HIP may be used as a single treatment or mixed with other
medical devices of the same range in order to make a customised
treatment according to clinical evolution.
When a supportive treatment is needed for acute pain, MD-HIP
can be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (together with one or more than one of these).
Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological aging process is
needed to be slowed down, MD-HIP can be associated with
MD-MATRIX and MD-TISSUE.
It may also be used as mechanical support while treating the
following diseases:
• Hip joint osteoarthritis.
• Hip joint capsule inflammation.
• Hip joint osteoarthritis with rheumatoid arthritis (in association
with MD-POLY).
• Hip joint pain of muscle origin (in association with MDMUSCLE).
• Hip joint pain of nerve origin (burning hip, in association with
MD-NEURAL).
• Hip joint pain due to prolonged bed rest

Directions for use

Therapeutic protocol:
1 treatment weekly for 10 consecutive weeks.
Periarticular injection technique (the site of application must be aseptic; insert
the needle at 6-8 mm depth)
For this purpose the use of the following materials and accessories is recommended:
• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride
spray for the skin.
• Needles: sterile 27 G.
• Syringes: 5 or 10 cc size, according to the volume of the
solution to inject.
Intraarticular injection technique
For this purpose the use of the following materials and accessories is recommended:
• Materials for aseptic skin preparation: single-use gloves, iodine solution, alcohol solution, sterile gauze pads, ethyl chloride spray for the skin.
The application of a topical anaesthetic on the skin area to be treated is recommended.
• Needles: sterile 22 G.
• Syringes: 2 cc size, according to the volume of the solution to inject.
Contraindications / Side effects
Patients treated with anticoagulants or with recognized vessel fragility should be carefully monitored during the therapy.
There is no history of hypersensitivity to MD-HIP. Patients with known hypersensitivity to any ingredient or excipient should be tested before use, making a spot injection into one arm and be monitored for 1 hour

COMPOSITIONS

Collagen, Calci phosphat, Natri clorid, water for injection.

USES

MD-HIP may be used as a single treatment or mixed with other medical devices of the same range in order to make a customised treatment according to clinical evolution.
When a supportive treatment is needed for acute pain, MD-HIP
can be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (together with one or more than one of these).
Moreover, when a supportive treatment is needed for the connective tissue matrix or when the physiological aging process is
needed to be slowed down, MD-HIP can be associated with MD-MATRIX and MD-TISSUE.
It may also be used as mechanical support while treating the
following diseases:
• Hip joint osteoarthritis.
• Hip joint capsule inflammation.
• Hip joint osteoarthritis with rheumatoid arthritis (in association with MD-POLY).
• Hip joint pain of muscle origin (in association with MD – MUSCLE).
• Hip joint pain of nerve origin (burning hip, in association with MD-NEURAL).
• Hip joint pain due to prolonged bed rest

Video Guide